Cargando…

Assessment of fracture risk in women with breast cancer using current vs emerging guidelines

BACKGROUND: Breast cancer (BC) therapies can have negative effects on bone. Current guidelines recommend antiresorptive therapy based on bone mineral density (BMD), and emerging guidelines include both clinical risk factors and BMD to assess the overall fracture risk. A retrospective, case–controlle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hadji, P, Ziller, M, Albert, U S, Kalder, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837568/ https://www.ncbi.nlm.nih.gov/pubmed/20087347 http://dx.doi.org/10.1038/sj.bjc.6605548

Ejemplares similares

Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care
por: Chiarelli, Anna M, et al.
Publicado: (2017)

Internet-based cognitive behavioral therapy for improving health-related quality of life in patients with endometriosis: study protocol for a randomized controlled trial
por: Schubert, Kathrin, et al.
Publicado: (2022)

Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review
por: Hind, D, et al.
Publicado: (2007)

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
por: Pfeiler, G, et al.
Publicado: (2013)

Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer
por: Patkar, V, et al.
Publicado: (2006)

Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom
por: Lester, J E, et al.
Publicado: (2006)

The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients
por: Jacke, Christian O., et al.
Publicado: (2015)

A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women
por: Shen, S, et al.
Publicado: (2015)

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer
por: Griebsch, I, et al.
Publicado: (2006)

Ovarian cancer in younger vs older women: a population-based analysis
por: Chan, J K, et al.
Publicado: (2006)

Comprehensive geriatric assessment in 326 older women with early breast cancer
por: Okonji, D O, et al.
Publicado: (2017)

Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
por: Schaapveld, M, et al.
Publicado: (2005)

A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer
por: De Placido, S, et al.
Publicado: (2005)

A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer
por: Jones, R L, et al.
Publicado: (2009)

Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer
por: Sutton, A J, et al.
Publicado: (2013)

Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines
por: Wyld, L, et al.
Publicado: (2004)

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
por: Stemmler, H J, et al.
Publicado: (2011)

Percutaneous Vertebral Augmentation with Polyethylene Mesh and Allograft Bone for Traumatic Thoracolumbar Fractures
por: Schulz, C., et al.
Publicado: (2015)

Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
por: Wishart, G C, et al.
Publicado: (2008)

Low Body Mass Index Can Identify Majority of Osteoporotic Inflammatory Bowel Disease Patients Missed by Current Guidelines
por: Atreja, Ashish, et al.
Publicado: (2012)

Patterns of metastasis in women with metachronous contralateral breast cancer
por: Vichapat, V, et al.
Publicado: (2012)

Mammographic Breast Density Patterns in Asymptomatic Mexican Women
por: Calderón-Garcidueñas, Ana Laura, et al.
Publicado: (2012)

Predictors of ovarian reserve in young women with breast cancer
por: Lutchman Singh, K, et al.
Publicado: (2007)

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience
por: Cutuli, B, et al.
Publicado: (2009)

Epirubicin–vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial
por: Kerbrat, P, et al.
Publicado: (2007)

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?
por: Séroussi, B, et al.
Publicado: (2013)

Osteoporosis among Fallers without Concomitant Fracture Identified in an Emergency Department: Frequencies and Risk Factors
por: Glintborg, Bente, et al.
Publicado: (2011)

Breast cancer awareness among older women
por: Linsell, L, et al.
Publicado: (2008)

Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer
por: Peate, M, et al.
Publicado: (2012)

Goal-Directed vs Traditional Approach to Intraoperative Fluid Therapy during Open Major Bowel Surgery: Is There a Difference?
por: Sujatha, Prabhu P., et al.
Publicado: (2019)

Morphological predictors of BRCA1 germline mutations in young women with breast cancer
por: Southey, M C, et al.
Publicado: (2011)

Adjuvant ovarian function suppression and cognitive function in women with breast cancer
por: Phillips, Kelly-Anne, et al.
Publicado: (2016)

Mammographic density and the risk of breast cancer in Japanese women
por: Nagata, C, et al.
Publicado: (2005)

Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer
por: Hamaoka, T, et al.
Publicado: (2010)

Choline and betaine intake and risk of breast cancer among post-menopausal women
por: Cho, E, et al.
Publicado: (2010)

Assessment of Regional Bone Density in Fractured Vertebrae Using Quantitative Computed Tomography
por: Soliman, Hany A.G., et al.
Publicado: (2017)

‘Being there' for women with metastatic breast cancer: a pan-European patient survey
por: Harding, V, et al.
Publicado: (2013)

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity
por: Helbekkmo, N, et al.
Publicado: (2007)

Value of Procollagen Type I Aminoterminal Propeptide in Women with Breast Cancer with regard to Metastases
por: Clouth, A., et al.
Publicado: (2011)

The association of waiting times from diagnosis to surgery with survival in women with localised breast cancer in England
por: Redaniel, M T, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ncf4c2hkqak8mcdqvlq12hd493